These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32580015)

  • 1. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
    Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
    Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
    Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
    Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma.
    Zou HY; Lv GQ; Dai LH; Zhan XH; Jiao JW; Liao LD; Zhou TM; Li CQ; Wu BL; Xu LY; Li EM
    Int J Biochem Cell Biol; 2016 Jun; 75():85-98. PubMed ID: 27063404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
    Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
    Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-protein interaction network analyses for elucidating the roles of LOXL2-delta72 in esophageal squamous cell carcinoma.
    Wu BL; Zou HY; Lv GQ; Du ZP; Wu JY; Zhang PX; Xu LY; Li EM
    Asian Pac J Cancer Prev; 2014; 15(5):2345-51. PubMed ID: 24716982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.
    Zhan XH; Jiao JW; Zhang HF; Xu XE; He JZ; Li RL; Zou HY; Wu ZY; Wang SH; Wu JY; Liao LD; Wang JJ; Cheng YW; Zhang K; Neufeld G; Xu LY; Li EM
    Cancer Res; 2019 Oct; 79(19):4951-4964. PubMed ID: 31409639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of potential roles of a new LOXL2 splicing variant using network knowledge in esophageal squamous cell carcinoma.
    Wu BL; Lv GQ; Zou HY; Du ZP; Wu JY; Zhang PX; Xu LY; Li EM
    ScientificWorldJournal; 2014; 2014():431792. PubMed ID: 25254241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
    Okada K; Moon HJ; Finney J; Meier A; Mure M
    Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia.
    Xu XH; Jia Y; Zhou X; Xie D; Huang X; Jia L; Zhou Q; Zheng Q; Zhou X; Wang K; Jin LP
    Exp Mol Med; 2019 Feb; 51(2):1-12. PubMed ID: 30804321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysyl oxidases: a novel multifunctional amine oxidase family.
    Csiszar K
    Prog Nucleic Acid Res Mol Biol; 2001; 70():1-32. PubMed ID: 11642359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.
    Li T; Xu L; Teng J; Ma Y; Liu W; Wang Y; Chi X; Shao S; Dong Y; Zhan Q; Liu X
    Dig Dis Sci; 2020 Apr; 65(4):1032-1041. PubMed ID: 31562612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin.
    Kim YM; Kim EC; Kim Y
    Mol Biol Rep; 2011 Jan; 38(1):145-9. PubMed ID: 20306300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
    Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation.
    Lugassy J; Zaffryar-Eilot S; Soueid S; Mordoviz A; Smith V; Kessler O; Neufeld G
    J Biol Chem; 2012 Jan; 287(5):3541-9. PubMed ID: 22157764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.
    Xia Q; Du Z; Chen M; Zhou X; Bai W; Zheng X; Lin L; Zhao Y; Ding J; Wu Z; Zou H; Wang S; Xu L; Li E; Wu B
    Mol Oncol; 2023 Nov; 17(11):2451-2471. PubMed ID: 37753805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
    Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.